Clinical Significance of Methacholine Bronchial Challenge Test in Differentiating Asthma From COPD

만성폐쇄성폐질환과 천식의 감별진단에서 메타콜린 기관지유발검사의 의의

  • Hong, Yun Kyung (Department of Internal Medicine, Chonbuk National University Medical School) ;
  • Chung, Chi Ryang (Department of Internal Medicine, Chonbuk National University Medical School) ;
  • Paeck, Kyung Hyun (Department of Internal Medicine, Chonbuk National University Medical School) ;
  • Kim, So Ri (Department of Internal Medicine, Chonbuk National University Medical School) ;
  • Min, Kyung Hoon (Department of Internal Medicine, Chonbuk National University Medical School) ;
  • Park, Seoung Ju (Department of Internal Medicine, Chonbuk National University Medical School) ;
  • Lee, Heung Bum (Department of Internal Medicine, Chonbuk National University Medical School) ;
  • Lee, Yong Chul (Department of Internal Medicine, Chonbuk National University Medical School) ;
  • Rhee, Yang Keun (Department of Internal Medicine, Chonbuk National University Medical School)
  • 홍윤경 (전북대학교 의과대학 내과학교실) ;
  • 정치량 (전북대학교 의과대학 내과학교실) ;
  • 백경현 (전북대학교 의과대학 내과학교실) ;
  • 김소리 (전북대학교 의과대학 내과학교실) ;
  • 민경훈 (전북대학교 의과대학 내과학교실) ;
  • 박성주 (전북대학교 의과대학 내과학교실) ;
  • 이흥범 (전북대학교 의과대학 내과학교실) ;
  • 이용철 (전북대학교 의과대학 내과학교실) ;
  • 이양근 (전북대학교 의과대학 내과학교실)
  • Received : 2006.09.18
  • Accepted : 2006.10.02
  • Published : 2006.11.30

Abstract

Background: Although airway hyper-responsiveness is one of the characteristics of asthma. bronchial hyper-responsiveness has also been observed to some degree in patients with chronic obstructive pulmonary disease (COPD). Moreover, several reports have demonstrated that a number of patients have both COPD and asthma. The methacholine bronchial challenge test (MCT) is a widely used method for the detecting and quantifying the airway hyper- responsiveness, and is one of the diagnostic tools in asthma. However, the significance of MCT in differentiating asthma or COPD combined with asthma from pure COPD has not been defined. The aim of this study was to determine the role of MCT in differentiating asthma from pure COPD. Method: This study was performed prospectively and was composed of one hundred eleven patients who had undergone MCT at Chonbuk National University Hospital. Sixty-five asthma patients and 23 COPD patients were enrolled and their MCT data were analyzed and compared with the results of a control group. Result: The positive rates of MCT were 65%, 30%, and 9% in the asthma, COPD, and control groups, respectively. The mean $PC_{20}$ values of the asthma, COPD, and control groups were $8.1{\pm}1.16mg/mL$, $16.9{\pm}2.21mg/mL$, and $22.0{\pm}1.47mg/mL$, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value of MCT for diagnosing asthma were 65%, 84%, 81%, and 69%, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value of MCT (ed note: please check this as I believe that these values correspond to the one $PC_{20}$ value. Please check my changes.) at the new cut-off points of$PC_{20}{\leq}16mg/ml$, were 80%, 75%, 78%, and 78%, respectively. Conclusion: MCT using the new cut-off point can be used as a more precise and useful diagnostic tool for distinguishing asthma from pure COPD.

연구배경: COPD 환자에서 천식을 동반한 환자들이 많이 있다고 보고 되어 있었고 기관지 과민성이 높은 비율로 보고되어 메타콜린 기관지유발검사가 이두 질환을 감별에 어떤 의의가 있는지 알아보았고, 치료에 대한 도움을 얻고자 연구하였다. 방 법: 전북대학교병원에서 2004년 1월부터 2004년 12월까지 메타콜린 기관지유발검사를 시행한 환자를 대상으로 전향적으로 연구하였다. 65명의 천식환자 23명의 COPD환자, 대조군에서 메타콜린 기관지유발검사를 분석하였다. 결 과: 각 군의 $PC_{20}$의 평균값은 천식군, COPD군 및 대조군에서 각각 $8.1{\pm}1.16$, $16.9{\pm}2.21$$22.0{\pm}1.47mg/mL$이고, 천식군, COPD군 및 대조군의 메타콜린 기관지유발검사의 양성율은 각각 65%, 30%와 9%였다. 메타콜린 기관지유발검사 양성 판정 기준을 $PC_{20}$ 16 mg/mL 이하로 가정할 때 천식군과 COPD군의 양성율은 80%와 30%이었고 민감도, 특이도, 양성예측률 및 음성예측률은 각각 80%, 75%, 78%와 78%였다. 결 론: 메타콜린 기관지유발검사의 양성기준을 $PC_{20}{\leq}16mg/mL$으로 하였을 때 천식 및 COPD가 동반된 천식과 순수한 COPD의 감별에 보다 많은 도움을 줄 것으로 예상되며 궁극적으로 COPD 환자들에게 보다 개별적이고 적절한 치료적 접근에 도달할 수 있도록 해주는 진단 방법 중 하나가 될 수 있다고 생각한다.

Keywords

References

  1. National Collaborating Centre for Chronic Conditions. National clinical guideline on management of chronic obstructive pulmonary disease in adult in primary and secondary care. Thorax 2004;59(Suppl):1-232
  2. Grootendorst DC, Rabe KF. Mecahnisms of bronchial hyperreactivity in asthmaand chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:77-87
  3. Burney PG, Britton JR, Chinn S, Tattersfield AE, Papacosta AO, Kelson MC, et al. Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax 1987;42: 38-44 https://doi.org/10.1136/thx.42.1.38
  4. Britton J, Pavord I, Richards K, Knox A, Wisniewski A, Wahedna I, et al. Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway caliber. Eur Respir J 1994;7:881-7
  5. Woolcock AJ, Peat JK, Salome CM, Yan K, Anderson SD, Schoeffel RE, et al. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult populacation Thorax 198742:361-8 https://doi.org/10.1136/thx.42.5.361
  6. Ernst P, Ghezzo H, Becklake MR. Risk factors for bronchial hyperresponsiveness in late childhood and early adolescence. Eur Respir J 2002;20:635-9 https://doi.org/10.1183/09031936.02.00962002
  7. Trigg CJ, Manolitsas ND, Wang J, Calderon MA, McAuley A, Jordan SE, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150:17-22 https://doi.org/10.1164/ajrccm.150.1.8025745
  8. Tashkin DP, Altos MD, Bleecker ER, Connett JE, Kanner RE, Lee WW, et al. The lung health study: airway responsiveness to inhaledmethacholin in smokers with mild to moderate airflow limitation. Am Rev Respir Dis 1992;145:301-10 https://doi.org/10.1164/ajrccm/145.2_Pt_1.301
  9. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999: this official statement of the American thoracic society was adopted by the ATS board of directors, July 1999. Am J Respir Crit Care Med 2000;161:309-29 https://doi.org/10.1164/ajrccm.161.1.ats11-99
  10. Sparrow D, O'Connor G, Colton T, Barry CL, Weiss ST. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function: the Normative Aging Study. Am Rev Respir Dis 1987;135:1255-60 https://doi.org/10.1164/arrd.1987.135.6.1255
  11. Taylor RG, Joyce H, Holland F, Pride NB. Bronhcial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and ex-smoker. Thorax 1985;40:9-16 https://doi.org/10.1136/thx.40.1.9
  12. Rhee YG, In BH, Lee YD, Lee YC, Lee HB. Prevalence of combined bronchial asthma with COPD in patients with moderate to severe air flow limitation. Tuberc Respir Dis 2003;54:386-94 https://doi.org/10.4046/trd.2003.54.4.386
  13. Sciurba FC. Physiologic similarities and differences between COPD and asthma. Chest 2004;126(2 Suppl): 117S-124S https://doi.org/10.1378/chest.126.2_suppl_1.117S
  14. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988. 1994. Arch Intern Med 2000;160:1683.9 https://doi.org/10.1001/archinte.160.11.1683
  15. Fabbri LM, Romagnoli M, Caorbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418-24 https://doi.org/10.1164/rccm.200203-183OC
  16. Oh SH, Hong CS, Lee HC, Huh KB, Lee WY, Lee SY. Evaluation of clinical significance of methacholine challenge test in asthma, allergic rhinitis, and chest symptom patients. Korean J Med1985;29:599-605
  17. Fish JE. Bronchial provocation testing. In: Middleton E, editor. Allergy: principles and practice. 4th ed. St.Louis:Mosby-Year Book 1993
  18. Ramsdell JW, Nachtwey FJ, Moser KM. Bronchial hyperreactivity in chronic obstructive bronchitis. Am Rev Respir Dis 1982;126:829-32
  19. Bahous J, Cartier A, Ouimet G, Pineau L, Malo JL. Nonallergic bronchial hyperexcitability in chronic bronchitis. Am Rev REspir Dis 1984;129:216-20
  20. Yan K, Salome CM, Woolcock AJ. Prevalence and nature of bronchial hyperresponsiveness in subjects with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;132:25-9
  21. Verma VK, Cockcroft DW, Dosman JA. Airway responsiveness to inhaled histamine in chronic obstructive airway disease: chronic bronchitis versus emphysema. Chest 1988;94:457-61 https://doi.org/10.1378/chest.94.3.457
  22. Rijcken B, Schouten JP, Weiss ST, Rosner B, de Vries K, van der Lende R. Long term-variability of bronchial responsiveness to histamine in a random population sample of adults. Am Rev Respir Dis 1993148: 944.9 https://doi.org/10.1164/ajrccm/148.4_Pt_1.944
  23. Perpina M, pellicer C, de Diego A, Compte L, Macian V. Diagnostic value of the bronchial provocation test with methacholine in asthma: a Bayesian analysis approach. Chest 1993104:149-54 https://doi.org/10.1378/chest.104.1.149